Molecular profiling of epigenetic landscape of cancer cells during extracellular matrix detachment

Mohammad Imran Khan1,2, Mazin A Zamzami3,4, Aftab Ahmad5

  • 1Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia. mikhan@kau.edu.sa.

Scientific Reports
|February 3, 2021
PubMed

Insights

Cancer cells evade cell death upon detachment by increasing EZH2 expression. Inhibiting EZH2 reduces cancer cell proliferation and metastasis, offering a potential therapeutic target for advanced cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Metastasis is a leading cause of cancer mortality, driven by tumor cells evading anoikis (programmed cell death) after detaching from the extracellular matrix (E.C.M.).
  • Understanding how cancer cells survive E.C.M. detachment is crucial for developing effective anti-metastasis therapies.

Purpose of the Study:

  • To investigate the role of oncogenic histone methyltransferases, specifically EZH2, in cancer cells that have detached from the E.C.M.
  • To evaluate the therapeutic potential of targeting EZH2 in E.C.M. detached cancer cells.

Main Methods:

  • Analysis of EZH2 expression and enzymatic activity in E.C.M. detached versus attached cancer cells.
  • Assessment of the effects of EZH2 inhibition on cell proliferation, spheroid formation, and apoptosis in detached cells.
  • Investigation of the interaction between EZH2 inhibition and AMPK signaling in E.C.M. detached cells.

Main Results:

  • EZH2 expression and activity were significantly elevated in E.C.M. detached cancer cells compared to attached cells.
  • Inhibition of EZH2 markedly reduced proliferation and spheroid size while increasing apoptosis in detached cancer cells.
  • E.C.M. detached cancer cells showed reduced EZH2 expression when single compared to clusters, and EZH2 inhibition demonstrated antagonistic effects with AMPK signaling.

Conclusions:

  • E.C.M. detached cancer cells rely on oncogenic EZH2 for survival and proliferation.
  • Targeting EZH2 with inhibitors presents a promising therapeutic strategy to combat cancer metastasis.

Related Concept Videos

The Extracellular Matrix01:29

The Extracellular Matrix

Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
11.0K
The Extracellular Matrix01:42

The Extracellular Matrix

Overview
87.1K
Extracellular Matrix01:26

Extracellular Matrix

Unlike epithelial tissue, which is composed of cells closely packed with little or no extracellular space in between, connective tissue cells are dispersed in a matrix. This extracellular matrix (ECM) is composed of fibrous proteins like collagen, elastin, and fibronectin in a ground substance consisting of interstitial fluid, cell adhesion proteins, and proteoglycans. The proteoglycans form a gel-like material in the spaces between cells and provide hydration, buffering, binding, and force...
4.5K
Overview of Cell-Matrix Interactions01:24

Overview of Cell-Matrix Interactions

The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...
8.4K